Perficient (PRFT)
(Delayed Data from NSDQ)
$73.81 USD
+0.01 (0.01%)
Updated May 29, 2024 04:00 PM ET
After-Market: $73.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$73.81 USD
+0.01 (0.01%)
Updated May 29, 2024 04:00 PM ET
After-Market: $73.81 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Zacks News
Here's What Could Help Perficient (PRFT) Maintain Its Recent Price Strength
by Zacks Equity Research
Perficient (PRFT) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Zacks.com featured highlights include: Encompass Health Corp, Perficient and Saia
by Zacks Equity Research
Zacks.com featured highlights include: Encompass Health Corp, Perficient and Saia
Time to Focus on Perficient (PRFT) for Strong Earnings Growth Potential
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Perficient (PRFT).
3 Stocks With Upgraded Broker Ratings to Buy Right Away
by Swayta Shah
By following broker ratings upgrades, you can easily find profitable stocks. So, we choose Encompass Health (EHC), Perficient (PRFT) and Saia (SAIA) as these have witnessed ratings upgrade.
FORR vs. PRFT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FORR vs. PRFT: Which Stock Is the Better Value Option?
Looking for a Growth Stock? 3 Reasons Why Perficient (PRFT) is a Solid Choice
by Zacks Equity Research
Perficient (PRFT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Perficient (PRFT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Perficient (PRFT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CACI or PRFT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CACI vs. PRFT: Which Stock Is the Better Value Option?
Perficient (PRFT) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Perficient (PRFT) delivered earnings and revenue surprises of 6.33% and 4.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Perficient (PRFT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Perficient (PRFT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CACI vs. PRFT: Which Stock Is the Better Value Option?
by Zacks Equity Research
CACI vs. PRFT: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights: CGI Group, Scientific Games and Perficient
by Zacks Equity Research
Zacks Industry Outlook Highlights: CGI Group, Scientific Games and Perficient
3 Stocks to Buy From the Flourishing Computer-Services Industry
by Aniruddha Ganguly
The Zacks Computer - Services industry players like CGI Group (GIB), Scientific Games (SGMS) and Perficient (PRFT) are poised to benefit from digital transformation and the consequent need for cyber security and cloud solutions.
5 Nasdaq-Based Tech Stocks That Have Returned More Than 50% YTD
by Aniruddha Ganguly
Here we discuss five Nasdaq-listed tech stocks -- Transcat (TRNS), Ultra Clean (UCTT), EMCORE (EMKR), Cambium (CMBM) and Perficient (PRFT) -- that have gained more than 50% year to date.
Here is Why Growth Investors Should Buy Perficient (PRFT) Now
by Zacks Equity Research
Perficient (PRFT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
CACI or PRFT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CACI vs. PRFT: Which Stock Is the Better Value Option?
Perficient (PRFT) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Perficient (PRFT) delivered earnings and revenue surprises of 10.29% and 1.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
MKS Instruments (MKSI) Q1 Earnings Top Estimates, Revenues Up
by Zacks Equity Research
MKS Instruments' (MKSI) Q1 results benefit from strength in the semiconductor market and recovery in advanced market revenues.
The Zacks Analyst Blog Highlights: Perficient, Citrix Systems, Texas Instruments, Avnet and MACOM Tech
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Perficient, Citrix Systems, Texas Instruments, Avnet and MACOM Tech
Perficient (PRFT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Perficient (PRFT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top 5 Nasdaq Stocks Set to Beat Earnings Estimate This Week
by Nalak Das
We have narrowed down our search to five Nasdaq Composite listed technology stocks slated to release earnings results this week. These are: AVT, CTXS, MTSI, PRFT and TXN.
Perficient (PRFT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Perficient (PRFT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CGI (GIB) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
CGI (GIB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Perficient (PRFT) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Perficient (PRFT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is Why Growth Investors Should Buy Perficient (PRFT) Now
by Zacks Equity Research
Perficient (PRFT) could produce exceptional returns because of its solid growth attributes.